PortfoliosLab logoPortfoliosLab logo
Core Scientific, Inc (CORZ)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US21874A1060
IPO Date
Jan 24, 2024

Highlights

Market Cap
$6.95B
Enterprise Value
$7.70B
EPS (TTM)
-$0.79
Total Revenue (TTM)
$319.02M
Gross Profit (TTM)
$37.90M
EBITDA (TTM)
-$162.48M
Year Range
$6.20 - $23.63
Target Price
$27.38
ROA (TTM)
-12.29%
ROE (TTM)
29.98%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Core Scientific, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Core Scientific, Inc (CORZ) has returned 2.75% so far this year and 106.63% over the past 12 months.


Core Scientific, Inc

1D
7.55%
1M
-11.84%
YTD
2.75%
6M
-16.61%
1Y
106.63%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 24, 2024, CORZ's average daily return is +0.42%, while the average monthly return is +9.14%. At this rate, your investment would double in approximately 0.7 years.

Historically, 56% of months were positive and 44% were negative. The best month was Jun 2024 with a return of +95.8%, while the worst month was Mar 2025 at -35.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, CORZ closed higher 53% of trading days. The best single day was Jun 4, 2024 with a return of +40.3%, while the worst single day was Jan 27, 2025 at -29.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202623.56%-5.67%-11.84%2.75%
2025-12.67%-9.05%-35.13%11.88%31.48%60.28%-20.68%5.98%25.02%20.07%-21.59%-13.80%3.63%
2024-14.53%27.89%-5.85%-17.23%62.12%95.79%4.84%5.85%14.92%12.06%34.54%-21.42%308.43%

Benchmark Metrics

Core Scientific, Inc has an annualized alpha of 100.62%, beta of 2.39, and R² of 0.19 versus S&P 500 Index. Calculated based on daily prices since January 25, 2024.

  • This stock captured 1285.96% of S&P 500 Index gains and 324.74% of its losses — amplifying both gains and losses, but participating more in upside than downside.
  • R² of 0.19 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
100.62%
Beta
2.39
0.19
Upside Capture
1,285.96%
Downside Capture
324.74%

Return for Risk

Risk / Return Rank

CORZ ranks 79 for risk / return — better than 79% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


CORZ Risk / Return Rank: 7979
Overall Rank
CORZ Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
CORZ Sortino Ratio Rank: 8080
Sortino Ratio Rank
CORZ Omega Ratio Rank: 7878
Omega Ratio Rank
CORZ Calmar Ratio Rank: 8181
Calmar Ratio Rank
CORZ Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Core Scientific, Inc (CORZ) and compare them to a chosen benchmark (S&P 500 Index).


CORZBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.40

0.90

+0.51

Sortino ratio

Return per unit of downside risk

2.15

1.39

+0.76

Omega ratio

Gain probability vs. loss probability

1.27

1.21

+0.06

Calmar ratio

Return relative to maximum drawdown

2.45

1.40

+1.06

Martin ratio

Return relative to average drawdown

4.83

6.61

-1.78

Explore CORZ risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Core Scientific, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Core Scientific, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Core Scientific, Inc was 64.95%, occurring on Apr 21, 2025. Recovery took 120 trading sessions.

The current Core Scientific, Inc drawdown is 34.67%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-64.95%Nov 25, 202499Apr 21, 2025120Oct 10, 2025219
-40.74%Nov 4, 202531Dec 17, 2025
-33.17%Mar 8, 202428Apr 17, 202424May 21, 202452
-29.74%Jul 17, 202414Aug 5, 202431Sep 18, 202445
-22.83%Jan 29, 20244Feb 1, 20245Feb 8, 20249

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Core Scientific, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Core Scientific, Inc is priced in the market compared to other companies in the Software - Infrastructure industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CORZ relative to other companies in the Software - Infrastructure industry. Currently, CORZ has a P/S ratio of 17.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items